Hasil Pencarian (1)
biotech | CAS: 953400-68-5
Lebrikizumab is a monoclonal antibody that binds to IL-13 with high affinity and slow off-rate.[L51374] It binds to a different epitope compared [tralokinumab].[A262874,A262879] On November 17, 2023, lebrikizumab was approved by the EMA under the brand nam…
Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAmino Acids, Peptides, and ProteinsAntibodies
+10
Target Protein:
Interleukin-13
Waktu ParuhThe mean eliminatio…
Vol. DistribusiBased on a populati…
KlirensIn the population P…
Genetik
-